ARTICLE | Clinical News
Fabrazyme agalsidase beta regulatory update
January 23, 2012 8:00 AM UTC
Sanofi's Genzyme Corp. unit said EMA approved its Framingham, Mass., manufacturing facility for the production of Fabry's disease therapy Fabrazyme agalsidase beta. Genzyme has experienced supply con...